International Society for Vaccines
879 views | +0 today
International Society for Vaccines
A site that reports on new publications relating to vaccines and vaccine development, and showcases work by Society members worldwide.
Curated by Ed Rybicki
Your new post is loading...
Your new post is loading...
Scooped by Ed Rybicki
October 10, 2024 8:43 AM
Scoop.it!

The International Society for Vaccines

The International Society for Vaccines | International Society for Vaccines | Scoop.it
ISV President’s Message
Linda S. Klavinskis, PhD (ISV President, 2024-2025)
Professor of Viral Immunology, Department of Infectious Diseases, King’s College London.
It is an honour and privilege to serve as President of the ISV, an association that brings together talented scientists from across the globe at all stages of their careers to exchange
No comment yet.
Scooped by Ed Rybicki
June 1, 9:49 AM
Scoop.it!

Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response | Nature Communications

A range of humoral related adverse events can occur after treatment of haematological malignancy with chimeric antigen receptor cell therapies. Here the authors characterise the persistence of humoral immunity and response to vaccination after patients receive B cell targeted chimeric antigen...
No comment yet.
Scooped by Ed Rybicki
June 1, 9:48 AM
Scoop.it!

EMA launches new advisory group on vaccine confidence

EMA launches new advisory group on vaccine confidence | International Society for Vaccines | Scoop.it
International panel of high-level experts will support EMA’s efforts to strengthen trust in vaccines...
No comment yet.
Scooped by Ed Rybicki
June 1, 9:46 AM
Scoop.it!

Why Suppressing Vaccine Studies Erodes Public Confidence in the FDA -

Why Suppressing Vaccine Studies Erodes Public Confidence in the FDA - | International Society for Vaccines | Scoop.it
The U.S. Food and Drug Administration just handed a gift to vaccine skeptics—not because the science is wrong, but because the optics are terrible.Reports that the FDA blocked or delayed studies confirming the safety of COVID-19 and shingles vaccines, based on millions of patient records, is a perfect...
No comment yet.
Scooped by Ed Rybicki
June 1, 9:46 AM
Scoop.it!

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results Anonymous (not verified) Wed, 05/20/2026 - 05:05 
No comment yet.
Scooped by Ed Rybicki
June 1, 9:45 AM
Scoop.it!

Global vaccine development | Nature Medicine

Global vaccine development | Nature Medicine | International Society for Vaccines | Scoop.it
The authors examine the vaccine landscape through two key areas of research and development—expanding target populations, and emerging vaccine technologies—and discuss cross-cutting issues, including the societal value of vaccines, funding and access, and regional manufacturing.
No comment yet.
Scooped by Ed Rybicki
June 1, 9:45 AM
Scoop.it!

PSG Workshop Rallies Health Workers Against Vaccine Misinformation | NewsGhana

PSG Workshop Rallies Health Workers Against Vaccine Misinformation | NewsGhana | International Society for Vaccines | Scoop.it
The Paediatrics Society of Ghana (PSG) has convened a regional workshop in Sunyani to arm frontline health workers with advocacy tools to counter rising vaccine misinformation and restore public confidence in immunisation programmes across the Bono, Bono East, and Ahafo regions.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:52 AM
Scoop.it!

Nigeria: West African Leaders Commit to Advance Lassa Fever Vaccine for the Region

Nigeria: West African Leaders Commit to Advance Lassa Fever Vaccine for the Region | International Society for Vaccines | Scoop.it
Blog - In an historic moment for regional solidarity and leadership, West African Ministers of Health today pledged their joint commitment to advance the development of, and readiness for, much-needed vaccines against Lassa fever in recognition of the significant threat to regional health security...
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:51 AM
Scoop.it!

An HIV Vaccine: An Unfulfilled Promise—Episode 4, Looking Toward a Fulfilled Promise

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode,Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina Russell discuss promising advances in the field of HIV vaccine research and how we can prepare for optimal rollout of an eventual HIV vaccine. 


Presenters:

Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD , PGD (Research Ethics), MBE (Research Ethics), CIP
Senior Principal Clinical Research Scientist
Center for Microbiology Research
KEMRI
Research Professor
Departments of Global Health and Obstetrics and Gynecology
University of Washington,
Nairobi, Kenya
Seattle, Washington


Peter Godfrey-Faussett, MBBS, FRCP(UK)
Science Advisor
United Nations Joint Programme on HIV (UNAIDS)
Professor of Infectious Diseases and International Health
London School of Hygiene and Tropical Medicine
London, United Kingdom


Nina Russell, MD
Director for TB and HIV Prevention
Bill & Melinda Gates Foundation
Seattle, Washington



Link to full series:  
https://bit.ly/2UgrQ12


Link to the HIV unmuted series from IAS: https://hivunmuted.iasociety.org/


Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:51 AM
Scoop.it!

An HIV Vaccine: An Unfulfilled Promise—Episode 2, Learning Through Failing

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.


Presenters:


Susan Buchbinder, MD
Clinical Professor
Departments of Medicine, Epidemiology and Biostatistics
University of California, San Francisco
Director, Bridge HIV
San Francisco Department of Public Health
San Francisco, California  


Jontraye Davis, MHA, PMD Pro
Community Program Manager 
FHI 360
Adjunct Instructor
North Carolina Central University
Durham, North Carolina


Special Commentator:  


Jerome H. Kim, MD
Director General
International Vaccine Institute
Seoul, South Korea


Link to full series:
https://bit.ly/3ytytMY


Link to the HIV unmuted series from IAS:
https://bit.ly/3f5qC0d


Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:51 AM
Scoop.it!

Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic | Nature Communications

Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic | Nature Communications | International Society for Vaccines | Scoop.it
Broad-spectrum vaccines have been proposed as a tool for rapid response to emerging infectious disease threats and are in pre-clinical development. Here, the authors use mathematical modelling to assess the potential impacts of broadly protective sarbecovirus vaccines for a hypothetical “SARS-X”...
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:50 AM
Scoop.it!

Uefa and Gavi use football to raise vaccine awareness in Africa

Uefa and Gavi use football to raise vaccine awareness in Africa | International Society for Vaccines | Scoop.it
UEFA and Gavi are working together to harness the power of football to raise awareness about vaccines in Africa.
No comment yet.
Scooped by Ed Rybicki
April 30, 2025 7:15 AM
Scoop.it!

Trial of 45 doctors for spreading anti-vaccine claims during Covid pandemic starts in Poland

Trial of 45 doctors for spreading anti-vaccine claims during Covid pandemic starts in Poland | International Society for Vaccines | Scoop.it
A trial has begun in Poland of 45 doctors who spread anti-vaccine claims during the Covid-19 pandemic. If found guilty of disseminating information inconsistent with medical knowledge, they could lose their medical licences. The doctors are part of a group, the Polish Association of Independent Physicians and Scientists (PSNLiN), that actively opposes the use of vaccines. “They signed a letter which falsely presented both the results of research on vaccines and the entire strategy to combat the pandemic,” Paweł Wróblewski, president of the Lower Silesian Medical Chamber, which is overseeing the case, told broadcaster TVN. “The doctors are accused of promoting anti-health attitudes and publicly disseminating information that is inconsistent with current medical knowledge, thereby acting to the detriment of patients and the entire society,” he added. 
No comment yet.
Scooped by Ed Rybicki
June 1, 9:49 AM
Scoop.it!

Creating cancer vaccine for specific patient takes about 3 months - Society & Culture

Creating cancer vaccine for specific patient takes about 3 months - Society & Culture | International Society for Vaccines | Scoop.it
The first patient in Russia received a domestically made personalized cancer vaccine April 1...
No comment yet.
Scooped by Ed Rybicki
June 1, 9:48 AM
Scoop.it!

[Shigeru Omi] Stay alert after Korea’s vaccine win

[Shigeru Omi] Stay alert after Korea’s vaccine win | International Society for Vaccines | Scoop.it
This year’s World Immunization Week (April 24-30) carries a simple but powerful message: “For every generation, vaccines work.” It is a timely reminder for Kore...
No comment yet.
Scooped by Ed Rybicki
June 1, 9:48 AM
Scoop.it!

Why do we have a vaccine for measles, but not cytomegalovirus (CMV)? | PLOS Pathogens

1. CMV and measles: Ubiquitous pediatric infectionsCytomegalovirus (CMV) and measles virus (MV) have historically been considered classical, ubiquitous viral infections, usually acquired in childhood. In each case, humans are the only host, although from an evolutionary perspective, MV is a relative “newcomer”, having jumped species from cattle-to-humans (initially as the related virus, Rinderpest morbillivirus) in the sixth century [1]. In contrast, all CMVs have co-evolved with their respective animal hosts for millions of years, with human CMV showing the greatest similarity to related primate CMVs [2]. 
No comment yet.
Scooped by Ed Rybicki
June 1, 9:46 AM
Scoop.it!

A New Hantavirus Vaccine Is in the Works

A New Hantavirus Vaccine Is in the Works | International Society for Vaccines | Scoop.it
Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.
No comment yet.
Scooped by Ed Rybicki
June 1, 9:45 AM
Scoop.it!

Bangladesh faces measles crisis with over 50,000 cases after Yunus govt changed vaccine procurement system

Bangladesh faces measles crisis with over 50,000 cases after Yunus govt changed vaccine procurement system | International Society for Vaccines | Scoop.it
Immunisation program collapsed in Bangladesh after Yunus govt changed vaccine procurement system, and now the country is facing a massive measles outbreak | OpIndia News...
No comment yet.
Scooped by Ed Rybicki
June 1, 9:45 AM
Scoop.it!

Scientists urge advocacy to protect vital global vaccine research

Scientists urge advocacy to protect vital global vaccine research | International Society for Vaccines | Scoop.it
Scientists and physicians should advocate to protect the vaccine research infrastructure that has saved an estimated 154 million lives over the past 50 years, according to a new commentary by researchers at Weill Cornell Medicine and the University of Washington.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:52 AM
Scoop.it!

Pakistan is set to introduce HPV vaccine for first time to prevent Cervical Cancer

Pakistan is set to introduce HPV vaccine for first time to prevent Cervical Cancer | International Society for Vaccines | Scoop.it
Pakistan is set to introduce HPV vaccine for first time to prevent Cervical Cancer...
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:52 AM
Scoop.it!

Russian Cancer Vaccine Ready to Be Launched

Russian Cancer Vaccine Ready to Be Launched | International Society for Vaccines | Scoop.it
Russia’s first personalized melanoma vaccines are poised for production, with patient treatment expected soon following promising preclinical results.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:51 AM
Scoop.it!

An HIV Vaccine: An Unfulfilled Promise—Episode 3, Increasing Global Advocacy and Funding

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden global advocacy and increase investment for an HIV vaccine.


Presenters:


Swati Gupta, DrPH, MPH
Vice President and Head of Emerging Infectious Diseases and Scientific Strategy
International AIDS Vaccine Initiative
New York, New York


Marc Dixneuf, PhD
Director General
AIDES
Pantin, France


Special Commentator:  


Jonathan Weber, MB, BChir, PhD, FRCP, FRCPath, FMed Sci
Dean of the Faculty of Medicine
Imperial College
London, United Kingdom


Link to full series:
https://bit.ly/3ytytMY


Link to the HIV unmuted series from IAS:
https://bit.ly/3f5qC0d


Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:51 AM
Scoop.it!

An HIV Vaccine: An Unfulfilled Promise− Episode 1, The Ultimate Game Changer

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this first episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.


Presenters:


Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD  
Chief Operating Officer  
Desmond Tutu HIV Foundation  
Deputy Director
Desmond Tutu HIV Centre  
Past President
International AIDS Society  
Faculty of Health Sciences  
University of Cape Town  
Cape Town, South Africa


Maureen Luba
Africa Region Advocacy Advisor
Global Advocacy for HIV Prevention
AIDS Vaccine Advocacy Coalition


Link to full series:
https://bit.ly/3ytytMY


Link to the HIV unmuted series from IAS:
https://bit.ly/3f5qC0d


Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.


 
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:51 AM
Scoop.it!

Vaccines and Society: Safeguarding Health for Generations –

Vaccines and Society: Safeguarding Health for Generations – | International Society for Vaccines | Scoop.it
Vaccines provide one of the most reliable defenses against infectious diseases. By stimulating the body’s immune system to recognize and fight off harmful pathogens, they create a protective barrier long before exposure occurs.
No comment yet.
Scooped by Ed Rybicki
October 8, 2025 6:50 AM
Scoop.it!

Robert F. Kennedy Jr. weaponizes an old antivax trope in his quest to eliminate vaccines

Robert F. Kennedy Jr. weaponizes an old antivax trope in his quest to eliminate vaccines | International Society for Vaccines | Scoop.it
People who whistle past the graveyard (of vaccines) to assure themselves the RFK Jr,. won't take away their vaccines are deluding themselves. It's on video!
No comment yet.
Scooped by Ed Rybicki
April 30, 2025 7:15 AM
Scoop.it!

The Critical Role Of Regional Vaccine Manufacturing In The Next Global Pandemic

The Critical Role Of Regional Vaccine Manufacturing In The Next Global Pandemic | International Society for Vaccines | Scoop.it
A greater weight must be placed on vaccine manufacturing and distribution, both in the United States and worldwide, as we saw major imbalances in the world's response to Covid-19 that highlighted gaps in accessibility.
No comment yet.